BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Treatment
269 results:

  • 1. B7-H3 Expression in Breast cancer and Brain Metastasis.
    Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Circular RNA circTATDN3 promotes the Warburg effect and proliferation in colorectal cancer.
    Lin J; Zhong W; Lyu Z; Peng J; Rong Y; Zeng K; Lai J; Wu D; Wang J; Li Y; Zheng J; Zhang J; Pan Z
    Cancer Lett; 2024 May; 589():216825. PubMed ID: 38548218
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Select EZH2 inhibitors enhance viral mimicry effects of DNMT inhibition through a mechanism involving NFAT:AP-1 signaling.
    Chomiak AA; Tiedemann RL; Liu Y; Kong X; Cui Y; Wiseman AK; Thurlow KE; Cornett EM; Topper MJ; Baylin SB; Rothbart SB
    Sci Adv; 2024 Mar; 10(13):eadk4423. PubMed ID: 38536911
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Synergic actions of botulinum neurotoxin A and oxaliplatin on colorectal tumour cell death through the upregulation of TRPM2 channel-mediated oxidative stress.
    Demir S; Duman İ; Nazıroğlu M
    Clin Exp Pharmacol Physiol; 2024 Apr; 51(4):e13844. PubMed ID: 38350599
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK.
    McCarthy G; Young K; Madin-Warburton M; Mantaian T; Brook E; Metcalfe K; Mikelson J; Xu R; Seyla-Hammer C; Aguiar-Ibáñez R; Amonkar M
    J Med Econ; 2024; 27(1):279-291. PubMed ID: 38293714
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Soluble B7-H3 in colorectal cancer.
    Kovaleva OV; Gratchev AN; Sokolov NY; Maslennikov VV; Kuzmin YB; Gershtein ES; Alferov AA; Mamedli ZZ; Stilidi IS; Kushlinskii NE
    Bull Exp Biol Med; 2023 Nov; 176(1):87-90. PubMed ID: 38085395
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Insight into the design of FGFR4 selective inhibitors in cancer therapy: Prospects and challenges.
    Chen X; Huang Y; Chen B; Liu H; Cai Y; Yang Y
    Eur J Med Chem; 2024 Jan; 263():115947. PubMed ID: 37976704
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. B7-H3 at the crossroads between tumor plasticity and colorectal cancer progression: a potential target for therapeutic intervention.
    Varghese E; Samuel SM; Brockmueller A; Shakibaei M; Kubatka P; Büsselberg D
    Cancer Metastasis Rev; 2024 Mar; 43(1):115-133. PubMed ID: 37768439
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Anticancer Study of a Novel Pan-HDAC Inhibitor MPT0G236 in colorectal cancer Cells.
    Tsai FL; Huang HL; Lai MJ; Liou JP; Pan SL; Yang CR
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628767
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer.
    Li W; Zhou C; Yu L; Hou Z; Liu H; Kong L; Xu Y; He J; Lan J; Ou Q; Fang Y; Lu Z; Wu X; Pan Z; Peng J; Lin J
    Autophagy; 2024 Jan; 20(1):114-130. PubMed ID: 37615625
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Molecular insights into recognition of GUCY2C by T-cell engaging bispecific antibody anti-GUCY2CxCD3.
    Rampuria P; Mosyak L; Root AR; Svenson K; Agostino MJ; LaVallie ER
    Sci Rep; 2023 Aug; 13(1):13408. PubMed ID: 37591971
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Preconditioning of radiotherapy enhances efficacy of B7-H3-CAR-T in treating solid tumor models.
    Wang T; Zhang K; You F; Ma R; Yang N; Tian S; An G; Yang L
    Life Sci; 2023 Oct; 331():122024. PubMed ID: 37574043
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. ADT-OH synergistically enhanced the antitumor activity of celecoxib in human colorectal cancer cells.
    Xu H; Li P; Ma H; Tan Y; Wang X; Cai F; Xu J; Sun H; Zhuang H; Hua ZC
    Cancer Med; 2023 Aug; 12(16):17193-17211. PubMed ID: 37492969
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. CNN2 silencing inhibits colorectal cancer development through promoting ubiquitination of EGR1.
    He J; Yang X; Zhang C; Li A; Wang W; Xing J; E J; Xu X; Wang H; Yu E; Shi D; Wang H
    Life Sci Alliance; 2023 Jul; 6(7):. PubMed ID: 37188478
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Two Cases of Transfusion-Free Hepatectomy Following Chemotherapy for H3 Grade of Simultaneous Liver Metastases].
    Ogawa T; Kawamoto S; Yamamoto K; Atarashi M; Terashima T; Kurogi N
    Gan To Kagaku Ryoho; 2023 Feb; 50(2):236-238. PubMed ID: 36807183
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancers.
    Zekri L; Lutz M; Prakash N; Manz T; Klimovich B; Mueller S; Hoerner S; Hagelstein I; Engel M; Chashchina A; Pfluegler M; Heitmann JS; Jung G; Salih HR
    Mol Ther; 2023 Apr; 31(4):1033-1045. PubMed ID: 36793213
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Whole-exome sequencing of rectal neuroendocrine tumors.
    Li Y; Guo Y; Cheng Z; Tian C; Chen Y; Chen R; Yu F; Shi Y; Su F; Zhao S; Wang Z; Luo J; Tan H
    Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 36645718
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Rational Design of a Triple Tumor Microenvironment-Responsive Nanoplatform for Enhanced Tumor Theranostics.
    Zhang S; Han X; Chen X; Liu Y; Zhou J
    Chemistry; 2023 Feb; 29(7):e202202469. PubMed ID: 36219493
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Recyclable Endogenous H
    Huang J; Deng Z; Bi S; Wen X; Zeng S
    Adv Sci (Weinh); 2022 Nov; 9(31):e2203902. PubMed ID: 36180395
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Epigallocatechin-3-gallate inhibits the formation of neutrophil extracellular traps and suppresses the migration and invasion of colon cancer cells by regulating STAT3/CXCL8 pathway.
    Zhang Z; Zhu Q; Wang S; Shi C
    Mol Cell Biochem; 2023 Apr; 478(4):887-898. PubMed ID: 36112238
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 14.